Page last updated: 2024-09-05

erlotinib hydrochloride and methanol

erlotinib hydrochloride has been researched along with methanol in 3 studies

Compound Research Comparison

Studies (erlotinib hydrochloride)	Trials (erlotinib hydrochloride)	Recent Studies (post-2010) (erlotinib hydrochloride)	Studies (methanol)	Trials (methanol)	Recent Studies (post-2010) (methanol)
4,353	786	3,033	30,195	168	13,002

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arrieta, O; Castillo-Gonzalez, P; de la Cruz Vargas, J; De la Garza, J; Flores-Estrada, D; Gonzalez, C; Gonzalez-De la Rosa, CH; Guzman, E; Hernandez-Pedro, N; Martinez-Barrera, L; Morales-Barrera, R; Rios-Trejo, MA; Téllez, E; Treviño, S	1
Cardona, AF; Reguart, N; Reveiz, L	1
Arrieta, O; Michel, RM; Rios Trejo, MA	1

Trials

1 trial(s) available for erlotinib hydrochloride and methanol

Article	Year
Wood-smoke exposure as a response and survival predictor in erlotinib-treated non-small cell lung cancer patients: an open label phase II study. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2008, Volume: 3, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Environmental Exposure; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; Lung Neoplasms; Middle Aged; Neoplasm Staging; Particulate Matter; Prognosis; Prospective Studies; Protein Kinase Inhibitors; Quinazolines; Smoke; Survival Rate; Wood	2008

Article

Year

Wood-smoke exposure as a response and survival predictor in erlotinib-treated non-small cell lung cancer patients: an open label phase II study.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2008, Volume: 3, Issue:8

Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Environmental Exposure; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; Lung Neoplasms; Middle Aged; Neoplasm Staging; Particulate Matter; Prognosis; Prospective Studies; Protein Kinase Inhibitors; Quinazolines; Smoke; Survival Rate; Wood

2008

Other Studies

2 other study(ies) available for erlotinib hydrochloride and methanol

Article	Year
Wood-smoke exposure (WSE) as a predictor of response and survival in erlotinib-treated non-small cell lung cancer (NSCLC) patients. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2009, Volume: 4, Issue:1 Topics: Adenocarcinoma; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; Inhalation Exposure; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Prognosis; Protein Kinase Inhibitors; Quinazolines; Smoke; Survival Rate; Wood	2009
Wood-smoke exposure as a response and survival predictor in erlotinib-treated nonsmall cell lung cancer patients. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2009, Volume: 4, Issue:8 Topics: Carcinoma, Non-Small-Cell Lung; Erlotinib Hydrochloride; Humans; Lung Neoplasms; Prognosis; Protein Kinase Inhibitors; Quinazolines; Smoke; Survival Rate; Wood	2009

Article

Year

Wood-smoke exposure (WSE) as a predictor of response and survival in erlotinib-treated non-small cell lung cancer (NSCLC) patients.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2009, Volume: 4, Issue:1

Topics: Adenocarcinoma; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; Inhalation Exposure; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Prognosis; Protein Kinase Inhibitors; Quinazolines; Smoke; Survival Rate; Wood

2009

Wood-smoke exposure as a response and survival predictor in erlotinib-treated nonsmall cell lung cancer patients.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2009, Volume: 4, Issue:8

Topics: Carcinoma, Non-Small-Cell Lung; Erlotinib Hydrochloride; Humans; Lung Neoplasms; Prognosis; Protein Kinase Inhibitors; Quinazolines; Smoke; Survival Rate; Wood

2009